Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bFGF Gel for Sensitive Skin
NCT06516939Recruiting
- Sponsor
- Shanghai Skin Disease Hospital
- Start
- Jun 2024
- Primary completion
- Jul 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised trial in sensitive skin syndrome (SSS) comparing bFGF Gel with Placebo Gel (2 arms). Primary endpoint: Erythema Index at 4 weeks. Started Jun 2024; status: recruiting.
02
Drugs
recombinant bovine basic fibroblast growth factor
03
Conditions
sensitive skin syndrome (SSS)
Beyond the preview
Go deeper on NCT06516939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06516939.